Im Cannabis Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Im Cannabis Stock Summary

Im Cannabis competes with Connect Biopharma, Acumen Pharmaceuticals, Nuvation Bio, Eledon Pharmaceuticals, and Eliem Therapeutics. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States.

Im Cannabis Key Financial Ratios

Im Cannabis Key Balance Sheet Accounts

Im Cannabis Key Income Statement Accounts

Im Cannabis Key Cash Accounts

IMCC Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Im Cannabis's current stock value. Our valuation model uses many indicators to compare Im Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Im Cannabis competition to find correlations between indicators driving Im Cannabis's intrinsic value. More Info.Im Cannabis Corp is rated below average in return on equity category among its peers. It is rated third overall in return on asset category among its peers . At present, Im Cannabis' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Im Cannabis' earnings, one of the primary drivers of an investment's value.

Im Cannabis Corp Systematic Risk

Today, most investors in Im Cannabis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Im Cannabis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Im Cannabis growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Im Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Im Cannabis Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Im Cannabis Corp based on widely used predictive technical indicators. In general, we focus on analyzing IMCC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Im Cannabis's daily price indicators and compare them against related drivers.

When running Im Cannabis' price analysis, check to measure Im Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Im Cannabis is operating at the current time. Most of Im Cannabis' value examination focuses on studying past and present price action to predict the probability of Im Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Im Cannabis' price. Additionally, you may evaluate how the addition of Im Cannabis to your portfolios can decrease your overall portfolio volatility.